Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Sarcoma × pembrolizumab × Clear all

Phase

Status

Completed 11 Recruiting 9 Active not recruiting 8 Terminated 2 Withdrawn 1 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 10 Melanoma 8 Squamous Cell Carcinoma of Head and Neck 6 Head and Neck Neoplasms 6 Carcinoma, Transitional Cell 6 Breast Neoplasms 6 Triple Negative Breast Neoplasms 5 Pancreatic Neoplasms 5 Neoplasms 5 Multiple Myeloma 5 Carcinoma, Renal Cell 5 Recurrence 3 Lung Neoplasms 3 Endometrial Neoplasms 3 Colorectal Neoplasms 3 Stomach Neoplasms 2 Neoplasm Metastasis 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma 2 Kidney Neoplasms 2 Hematologic Neoplasms 2 Glioblastoma 2 Brain Neoplasms 2 Subcutaneous panniculitis-like T-cell lymphoma 1 Spinocerebellar Degenerations 1 Sezary Syndrome 1 Sarcoma, Synovial 1 Sarcoma, Kaposi 1 Sarcoma 1 Rectal Neoplasms 1

Interventions

Radiotherapy 5 Cyclophosphamide 4 pazopanib 3 Gemcitabine 3 Docetaxel 3 Biopsy 3 liposomal doxorubicin 2 Vincristine 2 Trastuzumab 2 Trabectedin 2 Temozolomide 2 Taxes 2 Surgical Procedures, Operative 2 Specimen Handling 2 Proton Therapy 2 Nivolumab 2 Ifosfamide 2 Filgrastim 2 Etoposide 2 Drug Therapy 2 Doxorubicin 2 Carboplatin 2 3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 2 trastuzumab biosimilar HLX02 1 tozuleristide 1 tislelizumab 1 selinexor 1 regorafenib 1 pirarubicin 1 pidilizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06494787 2025-02-24

SOC-2320

Sarcoma Oncology Research Center, LLC

Phase 2 Withdrawn

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡